Back
Research Affiliates Deletions ETF Vs. Kymera Therapeutics Industry Stock Comparison
Buy
80
NIXT
Research Affiliates Deletions ETF
Last Price:
26.77
Seasonality Move:
--
Buy
62
KYMR
Kymera Therapeutics
Last Price:
46.30
Seasonality Move:
65.72%
Buy
80
Research Affiliates Deletions ETF (NIXT)
is a Buy
Is Research Affiliates Deletions ETF a Buy, Sell or Hold?
- The current Research Affiliates Deletions ETF [NIXT] share price is $26.77. The Score for NIXT is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- NIXT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $46.41. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NIXT Stock Price Chart
What is Research Affiliates Deletions ETF's stock price today?
-
The Research Affiliates Deletions ETF share price today is $26.77
The current trend is relatively stagnant and NIXT is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.
NIXT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.91 | Buy |
Relative Strength Index (14 RSI): | 70.1 | Buy |
Chaikin Money Flow: | 7087 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.8 - 26.42) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.2 | Sell |
Relative Strength Index (14 RSI): | 51.28 | Buy |
Chaikin Money Flow: | 22833 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.9 - 49.54) | Sell |
Bollinger Bands (100): | (35.01 - 48.01) | Buy |
NIXT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.24 | Buy |
20-day SMA: | 26.12 | Buy |
50-day SMA: | 0 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 26.34 | Buy |
20-day EMA: | 24.58 | Buy |
50-day EMA: | 17.57 | Buy |
200-day EMA: | 6.36 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.1 | Buy |
20-day SMA: | 46.53 | Sell |
50-day SMA: | 46.23 | Buy |
200-day SMA: | 38.73 | Buy |
8-day EMA: | 45.83 | Buy |
20-day EMA: | 45.9 | Buy |
50-day EMA: | 45.24 | Buy |
200-day EMA: | 38.58 | Buy |
Research Affiliates Deletions ETF Earnings Growth & NIXT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
Research Affiliates Deletions ETF Technical Analysis
Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 17 | Oct 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |